OCM
LVAC

Oaktree Capital Management’s LAVA Medtech Acquisition Corp. Class A Common Stock LVAC Stock Holding History

Oaktree Capital Management’s Portfolio LVAC Stock Details LVAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-250,000
Closed -$2.5M – 429
2021
Q4 		$2.5M Buy
+250,000
New +$2.48M 0.03% 211

Other funds holding LVAC

BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
GL
Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return
SC
Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
PMAM
Picton Mahoney Asset Management Toronto, Ontario, Canada $13.5B AUM 50.48% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Oaktree Capital Management's LVAC Position: Q1 2022 in Review

Oaktree Capital Management sold out of LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) in Q1 2022, closing a stake of 250,000 shares — an estimated $2.5M sold.

Oaktree Capital Management first reported a position in LVAC in Q4 2021 and held it in 1 quarter. The position peaked at $2.5M in Q4 2021. 39 funds tracked by Wall St. Rank hold LVAC as of Q1 2022.

  • Oaktree Capital Management reported no remaining LAVA Medtech Acquisition Corp. Class A Common Stock position as of Q1 2022 after selling out during the quarter.
  • Oaktree Capital Management sold 250,000 LAVA Medtech Acquisition Corp. Class A Common Stock shares in Q1 2022, an estimated $2.5M.
  • Oaktree Capital Management first reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock in Q4 2021 and held it in 1 quarter.
  • Oaktree Capital Management's LAVA Medtech Acquisition Corp. Class A Common Stock position peaked at $2.5M in Q4 2021.
  • 39 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Class A Common Stock as of Q1 2022.

Based on Oaktree Capital Management's 13F filing for Q1 2022, filed 16 May 2022.